BR112013017489A2 - materiais e métodos para genotipagem e quantificação de um papiloma vírus humano de alto risco - Google Patents

materiais e métodos para genotipagem e quantificação de um papiloma vírus humano de alto risco

Info

Publication number
BR112013017489A2
BR112013017489A2 BR112013017489A BR112013017489A BR112013017489A2 BR 112013017489 A2 BR112013017489 A2 BR 112013017489A2 BR 112013017489 A BR112013017489 A BR 112013017489A BR 112013017489 A BR112013017489 A BR 112013017489A BR 112013017489 A2 BR112013017489 A2 BR 112013017489A2
Authority
BR
Brazil
Prior art keywords
methods
genotyping
quantifying
materials
papilloma virus
Prior art date
Application number
BR112013017489A
Other languages
English (en)
Other versions
BR112013017489B1 (pt
Inventor
Kobayashi Lori
Rangwala Sameera
Gay Tanya
Original Assignee
Qiagen Gaithersburg Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qiagen Gaithersburg Inc filed Critical Qiagen Gaithersburg Inc
Publication of BR112013017489A2 publication Critical patent/BR112013017489A2/pt
Publication of BR112013017489B1 publication Critical patent/BR112013017489B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/708—Specific hybridization probes for papilloma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

palente de invenção: materiais e métodos para genotipagem e quantificação de um papiloma vírus humano de alto risco. a presente invenção refere-se a ácidos nucleicos, ensaios e métodos para a detecção e quantificação de tipos de hpv de alto risco.
BR112013017489-7A 2011-01-07 2012-01-09 "métodos para genotipagem de hpv de alto risco e para distinguir entre infecções por hpv 16, hpv 18 e hpv 45". BR112013017489B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161430797P 2011-01-07 2011-01-07
US61/430,797 2011-01-07
PCT/US2012/020684 WO2012094682A2 (en) 2011-01-07 2012-01-09 Materials and method for genotyping and quantifying a high-risk human papillomavirus

Publications (2)

Publication Number Publication Date
BR112013017489A2 true BR112013017489A2 (pt) 2017-08-01
BR112013017489B1 BR112013017489B1 (pt) 2021-06-08

Family

ID=45607347

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013017489-7A BR112013017489B1 (pt) 2011-01-07 2012-01-09 "métodos para genotipagem de hpv de alto risco e para distinguir entre infecções por hpv 16, hpv 18 e hpv 45".

Country Status (8)

Country Link
US (1) US20120196274A1 (pt)
EP (1) EP2661508B1 (pt)
JP (1) JP2014501535A (pt)
CN (1) CN103517994A (pt)
AU (1) AU2012204158B2 (pt)
BR (1) BR112013017489B1 (pt)
CA (1) CA2823627C (pt)
WO (1) WO2012094682A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011210734B2 (en) * 2010-01-29 2017-02-09 Qiagen Gaithersburg, Inc. Methods and compositions for sequence-specific purification and multiplex analysis of nucleic acids
CN105324492A (zh) * 2013-03-26 2016-02-10 健能泰格技术公司 用于dna和rna检测的双探针：反探针组合物
US9771571B2 (en) 2014-02-28 2017-09-26 Gen-Probe Incorporated Method of isolating nucleic acid from specimens in liquid-based cytology preservatives containing formaldehyde
US9771572B2 (en) 2014-02-28 2017-09-26 Gen-Probe Incorporated Method of isolating nucleic acid from specimens in liquid-based cytology preservatives containing formaldehyde
AU2014384731B2 (en) 2014-02-28 2017-12-14 Gen-Probe Incorporated Method of isolating nucleic acid from specimens in liquid-based cytology preservatives containing formaldehyde
GB2559919B (en) 2014-02-28 2018-11-14 Gen Probe Inc Method of isolating nucleic acid from specimens in liquid-based cytology preservatives containing formaldehyde
CN110317901B (zh) * 2019-06-06 2023-05-16 圣湘生物科技股份有限公司 用于高危型hpv检测、分型的组合物、试剂盒及方法
CN114214343A (zh) * 2021-11-15 2022-03-22 上海市东方医院（同济大学附属东方医院） 一组高危型HPV整合所致的宫颈癌中特异表达的mRNA序列

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981179A (en) 1991-11-14 1999-11-09 Digene Diagnostics, Inc. Continuous amplification reaction
DK0746627T3 (da) 1994-02-21 2002-12-16 Stichting Res Fonds Pathologie Påvisning af human papillomavirus ved hjælp af en nukleinsyreamplifikationsproces, som anvender generelle primere
US6686151B1 (en) 1998-02-06 2004-02-03 Digene Corporation Immunological detection of RNA:DNA hybrids on microarrays
US5994079A (en) 1998-02-06 1999-11-30 Digene Corporation Direct detection of RNA mediated by reverse transcriptase lacking RNAse H function
CA2229955C (en) * 1998-02-20 2003-12-09 Medigene Gmbh Papilloma virus capsomere vaccine formulations and methods of use
US6420106B1 (en) * 1999-06-09 2002-07-16 Quantovir Ab Method and kit for early cancer prediction
US6200746B1 (en) * 1999-08-25 2001-03-13 Pharmacia & Upjohn Company Methods of identifying anti-viral agents
US7439016B1 (en) 2000-06-15 2008-10-21 Digene Corporation Detection of nucleic acids by type-specific hybrid capture method
US7601497B2 (en) 2000-06-15 2009-10-13 Qiagen Gaithersburg, Inc. Detection of nucleic acids by target-specific hybrid capture method
ES2276948T3 (es) * 2001-08-23 2007-07-01 MERCK & CO., INC. Ensayos pcr de hp multiplex fluorescente que usan fluoforos multiples.
SI1421200T1 (sl) * 2001-08-23 2007-04-30 Merck & Co Inc Poskusi PCR fluorescentnih multipleks HPV-jev z uporabo vec fluoroforov
IL162722A0 (en) * 2002-01-07 2005-11-20 Norchip As Method for detecting human papillomarirus mrna
GB0200239D0 (en) * 2002-01-07 2002-02-20 Norchip As Method for detecting human papillomavirus mRNA
EP1651660B1 (en) * 2003-08-08 2018-01-24 Sangamo Therapeutics, Inc. Methods and compositions for targeted cleavage and recombination
WO2008139938A1 (ja) * 2007-05-02 2008-11-20 National University Corporation Tokyo Medical And Dental University ヒトパピローマウイルス１６型遺伝子を標的とする二本鎖核酸分子及びそれを含む医薬
HUE029729T2 (en) * 2007-11-01 2017-03-28 Self-Screen B V A new method for detecting cervical HPVs
AU2009238247B2 (en) 2008-04-17 2014-12-11 Qiagen Gaithersburg, Inc. Compositions, methods, and kits using synthetic probes for determining the presence of a target nucleic acid
WO2010004251A1 (en) * 2008-06-16 2010-01-14 Oncomethylome Sciences Sa Dna methylomes
EP2419143B8 (en) * 2009-04-13 2018-06-27 INSERM - Institut National de la Santé et de la Recherche Médicale Hpv particles and uses thereof

Also Published As

Publication number Publication date
EP2661508A2 (en) 2013-11-13
WO2012094682A2 (en) 2012-07-12
BR112013017489B1 (pt) 2021-06-08
CA2823627A1 (en) 2012-07-12
EP2661508B1 (en) 2018-09-12
WO2012094682A3 (en) 2012-12-06
US20120196274A1 (en) 2012-08-02
JP2014501535A (ja) 2014-01-23
AU2012204158B2 (en) 2017-02-02
AU2012204158A1 (en) 2013-08-01
CA2823627C (en) 2021-05-11
CN103517994A (zh) 2014-01-15

Similar Documents

Publication Publication Date Title
BR112013017489A2 (pt) materiais e métodos para genotipagem e quantificação de um papiloma vírus humano de alto risco
CO6801646A2 (es) Eliminación de células diana por parte de células t citotóxicas específicas de virus utilizando complejos que comprenden mhc de clase i
CR20140169A (es) Proteinas de union al antigeno cd27l
EP2723855A4 (en) MUTANTS OF THE INFLUENZAVIRUS AND ITS USE
GT201300293A (es) 4-aril-n-fenil-1,3,5-triazin-2-aminas que contienen un grupo sulfoximina.
EP2700009A4 (en) ANALYSIS OF ELECTRONIC MESSAGES FOR THE DETECTION OF MALICIOUS SOFTWARE
DK3424532T3 (da) Influenzavirus-antistofsammensætninger
EP2626425A4 (en) NEUTRALIZING ANTIBODIES OF THE INFLUENZA VIRUS AND ITS SCREENING METHOD
DE112012001092A5 (de) Begrenzung der Aktivierung eines Ausweichassistenten
DK2993183T3 (da) Anti-hpv e7-antistoffer
BR112013021144A2 (pt) detecção quantitativa altamente multiplexada de ácidos nucléicos
IN2014KN02769A (pt)
DK3339865T3 (da) Assay for jc-virus-antistoffer
BR112014015547A2 (pt) método de detecção e quantificação de dna por meio de hibridização e manipulação de moléculas isoladas
HK1213603A1 (zh) 用於登革熱病毒的檢測、定量和血清分型的方法和試劑
SI2427576T1 (sl) Generični testi za odkrivanje virusov influence
CL2008000249A1 (es) Uso de una molecula de acido nucleico que codifica al menos un polipeptido e2 del papilomavirus, un vector o una particula virica infecciosa que la comprenda para tratar una infeccion permanente por papilomavirus causada por al menos un papilomavirus
EP3045914A4 (en) Method for measuring influenza b virus
BR112012018545A2 (pt) método de determinação e confirmação da presença de um hpv em uma amostra
HK1202924A1 (zh) 用於流感病毒血凝素的測定
EP3045913A4 (en) Sample processing method for influenza virus immunoassay, and immunoassay method
BR122020012978A8 (pt) Método de quantificação de um produto específico em uma reação de amplificação por corte e extensão (near)
BR112012021379A2 (pt) processo para a preparação de um alqueno
ITMI20120877A1 (it) Addotto di alogenuro di magnesio, componente catalitico/catalizzatore comprendente addotto di alogenuro di magnesio e sua preparazione.
CL2013001219A1 (es) Metodo para producir virus monoglucosilado de influenza; virus monoglucosilado del antígeno de influenza ha (virus completo o recombinante); uso del virus para preparar vacuna.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B09W Correction of the decision to grant [chapter 9.1.4 patent gazette]

Free format text: RETIFICACAO DA PUBLICACAO DEVIDO A INCORRECOES NO TITULO DO RELATORIO DE EXAME TECNICO E NO QUADRO 1 DO PARECER DE DEFERIMENTO.

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 09/01/2012, OBSERVADAS AS CONDICOES LEGAIS.

B25D Requested change of name of applicant approved

Owner name: QIAGEN GAITHERSBURG, LLC (US)

B25G Requested change of headquarter approved

Owner name: QIAGEN GAITHERSBURG, LLC (US)

B25L Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled

Owner name: QIAGEN GAITHERSBURG, LLC (US)

Free format text: ANULADA A PUBLICACAO CODIGO 25.7 NA RPI NO 2641 DE 17/08/2021 POR TER SIDO INDEVIDA.

B25L Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled

Owner name: QIAGEN GAITHERSBURG, INC. (US)

Free format text: ANULADA A PUBLICACAO CODIGO 25.4 NA RPI NO 2640 DE 10/08/2021 POR TER SIDO INDEVIDA.

B25D Requested change of name of applicant approved

Owner name: QIAGEN GAITHERSBURG, LLC (US)

B25G Requested change of headquarter approved

Owner name: QIAGEN GAITHERSBURG, LLC (US)